Trending

TCR

GSK begins cancer cell therapy tie-up with Immatics

GSK begins cancer cell therapy tie-up with Immatics

Cancer biotech Immatics has begun a collaboration with GlaxoSmithKline to develop novel therapies built around its T-cell-based technology.

X

GSK begins cancer cell therapy tie-up with Immatics

https://pharmaphorum.com/news/gsk-begins-cancer-cell-therapy-tie-up-with-immatics/

Change at the top at Adaptimmune as Noble stands down

Change at the top at Adaptimmune as Noble stands down

The long-serving CEO and founder of UK biotech Adaptimmune, James Noble, is standing down, to be replaced by

X

Change at the top at Adaptimmune as Noble stands down

https://pharmaphorum.com/news/change-at-the-top-at-adaptimmune-as-noble-stands-down/

Kite outlines vision for next gen cancer killing cells

Kite outlines vision for next gen cancer killing cells

Backed by Amgen, Kite outlines bold plan for developing CAR-T and TCR cells.

X

Kite outlines vision for next gen cancer killing cells

https://pharmaphorum.com/news/kite-outlines-vision-next-gen-cancer-killing-cells/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com